Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer

Challenges in Development of Targeted Liposomal Therapeutics

(2012) Rupa R. Sawant et al.   AAPS Journal

Nanoparticle Delivery of Cancer Drugs

(2011) Andrew Z. Wang et al.   Annual Review of Medicine

Update on the Relationship of Fish Intake with Prostate, Breast, and Colorectal Cancers

(2011) Aleix Sala-Vila et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

How do tenascins influence the birth and life of a malignant cell?

(2011) Florence Brellier et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs

(2011) Thordur Oskarsson et al.   NATURE MEDICINE

CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics

(2010) Long Xu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Evolving Treatment of Advanced Colon Cancer

(2009) Neil H. Segal et al.   Annual Review of Medicine

Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody

(2009) T. A. ElBayoumi et al.   CLINICAL CANCER RESEARCH

Inhibition of Colon Cancer Growth by Methylselenocysteine-Induced Angiogenic Chemomodulation Is Influenced by Histologic Characteristics of the Tumor

(2009) Arup Bhattacharya et al.   Clinical Colorectal Cancer

Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan

(2009) Huan He et al.   GLYCOCONJUGATE JOURNAL

Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity

(2009) Suk Hyun Jung et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeted delivery of doxorubicin using stealth liposomes modified with transferrin

(2009) XueMing Li et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues

(2009) Shweta R. Urva et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

(2008) Frank Alexis et al.   MOLECULAR PHARMACEUTICS

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein

(2008) Fa Yun Zhang et al.   PHARMACEUTICAL RESEARCH